Fundraising Fox
Abbie Celniker
InvestorPartner at Third Rock Ventures · Board director at Cedilla Therapeutics, Inc. · Board director at Rheos Medicines · Board director at Goldfinch BioPharma
Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Abbie
145 people in our graph can introduce you to Abbie.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Noubar Afeyan to introduce you to Abbie
You →Noubar · together at Eleven Biotherapeutics (2011–2014) →Abbie
Ask Jamie Chen to introduce you to Abbie
You →Jamie · 4 people · together at Eleven Biotherapeutics →Abbie
Ask Sam Okafor to introduce you to Abbie
You →Sam · 5 people · together at Alexion Pharmaceuticals →Abbie
Sign up to find every way you can get introduced to Abbie
- Your email: the people you already email who know Abbie
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Abbie
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
A biotech executive with over 30 years in senior R&D and leadership roles, she joined Third Rock Ventures in 2016, where she focuses on the formation, development, and strategy of portfolio companies. She previously served as CEO of Eleven Biotherapeutics and Taligen Therapeutics, and held senior roles at Novartis, Millennium Pharmaceuticals, and Wyeth.
Contact· published on Abbie's own website
Invests in
BiotechMedical Devices
Board director at Cedilla Therapeutics, Inc.
Intro paths
In turn, Abbie can intro founders to Cedilla Therapeutics, Inc.'s investors below.
Cedilla Therapeutics, Inc.'s investors · 2
Board director at Rheos Medicines
Intro paths
In turn, Abbie can intro founders to Rheos Medicines's investors below.
Rheos Medicines's investors · 1
Board director at Goldfinch BioPharma
Intro paths
In turn, Abbie can intro founders to Goldfinch BioPharma's investors below.
Goldfinch BioPharma's investors · 1
Experience
- Third Rock VenturesPartnercurrent2016 — present
- Eleven BiotherapeuticsCEO2011 — 2016Cambridge, MA
- Alexion PharmaceuticalsSVP, Translational Medicine2011
- Taligen Therapeutics Inc.CEO2006 — 2011
- NovartisGlobal Head of Biologics2006 — 2008
- Millennium Pharmaceuticals, Inc.SVP, Pharmacuetical Sciences and Strategy and Operations2000 — 2006
- Wyeth BiotechVP Protein Technologies1998 — 2000
- Genetics InstituteDirector, Antibody Technologies and Bioanalytical Sciences1993 — 1998
- GenentechAssociate Director, Biological Assay Development1986 — 1993
Skills & more
+8 more
Clinical DevelopmentDrug DiscoveryPharmacologyTranslational MedicineBioanalysisLife SciencesDrug DevelopmentTechnology TransferFrom Abbie's professional profile.
Deals · 6
Cedilla Therapeutics, Inc.Board seat
via Third Rock Ventures · filed Oct 2021 · $82.6M raise
Goldfinch BioPharmaBoard seat
via Third Rock Ventures · filed Jul 2020
PanOpticaBoard seat
via Third Rock Ventures · filed Apr 2019 · $47.3M raise
Rheos MedicinesBoard seat
via Third Rock Ventures · filed Nov 2018
Eleven BiotherapeuticsBoard seat
via Third Rock Ventures · filed Apr 2018 · $996K raise
ImaginabBoard seat
via Third Rock Ventures · filed Apr 2016 · $9.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Abata TherapeuticsAbata TherapeuticsFlare Therapeutics
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Third Rock Ventures
Network10
Investors connected to Abbie in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Abbie Celniker?
- A biotech executive with over 30 years in senior R&D and leadership roles, she joined Third Rock Ventures in 2016, where she focuses on the formation, development, and strategy of portfolio companies. She previously served as CEO of Eleven Biotherapeutics and Taligen Therapeutics, and held senior roles at Novartis, Millennium Pharmaceuticals, and Wyeth.
- Where does Abbie Celniker work?
- Abbie Celniker is Partner at Third Rock Ventures and Board director at Cedilla Therapeutics, Inc. and Board director at Rheos Medicines and Board director at Goldfinch BioPharma.
- What does Abbie Celniker invest in?
- Abbie Celniker invests in Biotech, Medical Devices.
- What check size does Abbie Celniker write?
- Abbie Celniker typically writes checks of $100K – $5M.
- What boards does Abbie Celniker sit on?
- Abbie Celniker holds tracked board seats at Abata Therapeutics, Abata Therapeutics, Cedilla Therapeutics, Inc., Eleven Biotherapeutics, Flare Therapeutics, Goldfinch BioPharma, Imaginab, PanOptica, Rheos Medicines.
- What companies has Abbie Celniker invested in?
- Investments tracked here include Abata Therapeutics, Flare Therapeutics, Merida Biosciences.
- Where did Abbie Celniker go to school?
- Abbie Celniker studied at University of Arizona College of Medicine – Tucson (PhD, Molecular Biology); UC San Diego (Bachelor of Sciences, Biology).
Founder mafias
UC San Diego mafia298
Also came through, then founded or led a company.
Third Rock Ventures mafia25
Also came through, then founded or led a company.
Alexion Pharmaceuticals mafia7
Also came through, then founded or led a company.
Imaginab mafia2
Also came through, then founded or led a company.
University of Arizona College of Medicine – Tucson mafia2
Also came through, then founded or led a company.
Same school
Also attended University of Arizona College of Medicine – Tucson5
Also attended UC San Diego577
+ 571 more
Shared employers
Also worked at Eleven Biotherapeutics6
Also worked at Alexion Pharmaceuticals28
+ 22 more
Also worked at Novartis330
+ 324 more
Also worked at Wyeth Biotech400
+ 394 more